GLUE — Monte Rosa Therapeutics, Inc. | XLV Holdings | StockAdder

(GLUE)

Monte Rosa Therapeutics, Inc.

Live chart and latest GLUE stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

GLUE News

Markus Warmuth sells 5,466 shares of GLUE (NASDAQ: GLUE) under Rule 144

Apr 14, 2026 MarketBeat

Philip Nickson Sells 5,845 Shares of Monte Rosa Therapeutics (NASDAQ:GLUE) Stock

Apr 10, 2026 Yahoo Finance

Monte Rosa Therapeutics (GLUE) Reports Q4 Loss, Misses Revenue Estimates

Mar 17, 2026 National Today

Monte Rosa Therapeutics Insider Sells Over $100K in Shares

Apr 11, 2026 simplywall.st

The Market Doesn't Like What It Sees From Monte Rosa Therapeutics, Inc.'s (NASDAQ:GLUE) Revenues Yet As Shares Tumble 26%

Feb 14, 2026 Stock Titan

Edmund Dunn files Form 144 reporting GLUE (NASDAQ: GLUE) common stock sales

Apr 13, 2026 Yahoo Finance

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Oct 29, 2025 MarketBeat

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Given Consensus Rating of "Moderate Buy" by Brokerages

Mar 27, 2026 Stock Titan

Insider at Monte Rosa Therapeutics (GLUE) sells 5,845 shares

Apr 10, 2026 Yahoo Finance

Assessing Monte Rosa Therapeutics (GLUE) Valuation After MRT-2359 Data Update And New Public Offering

Mar 7, 2026 Stock Titan

[144] Monte Rosa Therapeutics, Inc. SEC Filing

Apr 9, 2026 Yahoo Finance

Monte Rosa Therapeutics, Inc.'s (NASDAQ:GLUE) institutional investors lost 12% last week but have benefitted from longer-term gains

Feb 6, 2026 Yahoo Finance

Monte Rosa Therapeutics (GLUE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Mar 12, 2026 Stock Titan

26,117 GLUE shares reported for sale (NASDAQ: GLUE) in Form 144

Apr 8, 2026 Stock Titan

Monte Rosa Therapeutics (NASDAQ: GLUE) officer reports stock and option holdings in Form 3